Strategic long term, immunologically driven treatment interruptions in previously naive patients starting HAART: a controlled, randomized, multicenter study

Registry ID

EUCTR2006-002805-30

Source registry

EUCTR

Status

Ongoing

Phase

PHASE3

Sponsor

AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE)

Start date

2006-06-29

Last update

2026-08-16

Conditions

• HIV INFECTION

Summary

 To compare immunologic, virologic and clinical efficacy and safety of a conventional HAART in chronically infected HIV patients to a therapeutic strategy based on long term, immunologically driven treatment interruptions.  To verify the feasibility of an STI strategy in patients starting their first line HAART regimen with CD4 < 200 cells/l

Locations

• , , Italy

View on source registry